Strategy
Director, Medical Writing
Opportunity summary
Location: Copenhagen, DenmarkReporting to: Snr Director, Medical WritingHemab is building preventative treatments for serious, underserved bleeding disorders. These therapies are designed to work with the body's own biology and stop bleeds before they start, instead of treating them after they happen.
We're patient-first, science-led and clinical-stage, with a pipeline that takes different scientific approaches to different patient needs. We went public via our 2026 IPO, and we're scaling across two homes:
Cambridge, MA, USA, and Copenhagen, Denmark.
The role
As Director, Medical Writing, you will be dedicated to one of our compounds under clinical development, taking ownership of the clinical and regulatory writing that helps move this compound through development. You will turn complex clinical and scientific evidence into clear, accurate documents that regulators can act on - connecting the science, data and development strategy into one coherent story.
This is a hands-on role. You will write, shape and drive documents yourself while bringing physicians, scientists, biostatisticians and regulatory colleagues together around high-quality outputs and demanding timelines1 …
This is a shortened extract from the public vacancy. Follow the original posting for the complete and authoritative description.